TP53 and cancer: Using a mutant mouse model of p53-3KR (K120R, K161R, and K162R), researchers found that Trp53 can still inhibit cancer initiation, mainly by regulating cell metabolism, despite losing the antitumor effect of inducing cell cycle arrest, apoptosis, and senescence (93).